BioDlink revenue falls 23%, company shifts to net loss

BioDlink International Company Limited reported unaudited revenue of RMB621,670 thousand for the nine months ended 30 September 2025, marking a 23% decrease compared to the same period in 2024. This decline is primarily attributed to intensifying market competition for self-developed products. The company also shifted from a net profit of RMB35,403 thousand in the prior year to a net loss of RMB3,371 thousand for the current period.

Total comprehensive loss for the period reached RMB5,613 thousand, a significant downturn from the RMB35,771 thousand in total comprehensive income reported for the nine months ended 30 September 2024. Despite the decline, the company's total net assets remained relatively stable at RMB725,673 thousand as of 30 September 2025, compared to RMB729,655 thousand at 31 December 2024.

These unaudited figures, released due to disclosure requirements from Center Laboratories, Inc., a substantial shareholder, are subject to internal review and have not been audited by the company's external auditor or the Audit and Connected Transactions Review Committee.